OptimizeRx (OPRX) Short-term Investments (2022 - 2023)

OptimizeRx has disclosed Short-term Investments across 2 years of filings, most recently posting $53.6 million for Q3 2023.

• In Q3 2023, Short-term Investments rose 43.11% year-over-year to $53.6 million; the TTM figure through Sep 2023 stood at $53.6 million (up 43.11% YoY), while the FY2022 annual figure was $55.9 million, changed N/A from the prior year.
• Short-term Investments came in at $53.6 million for Q3 2023 at OptimizeRx, up from $52.9 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $57.3 million in Q1 2023 to a low of $37.5 million in Q3 2022.